$4.47
0.00%
Nasdaq, Mon, Aug 25 2025
ISIN
US14179K1016
Symbol
CRGX

CARGO Therapeutics Stock price

$4.47
-0.05 1.11% 1M
+0.59 15.21% 6M
-9.95 69.00% YTD
-12.82 74.15% 1Y
-10.53 70.20% 3Y
-10.53 70.20% 5Y
-10.53 70.20% 10Y
-10.53 70.20% 20Y
Nasdaq, Closing price Mon, Aug 25 2025
+0.00 0.00%
ISIN
US14179K1016
Symbol
CRGX
Industry

Key metrics

Basic
Market capitalization
$216.2m
Enterprise Value
$-36.4m
Net debt
positive
Cash
$252.6m
Shares outstanding
46.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.2
P/B
0.9
Financial Health
Equity Ratio
87.0%
Return on Equity
-46.5%
ROCE
-65.3%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-147.5m | $-140.8m
EBIT
$-155.2m | $-142.3m
Net Income
$-221.8m | $-132.0m
Free Cash Flow
$-191.8m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
2.7% | 21.9%
EBIT
-0.9% | 24.1%
Net Income
-50.1% | 21.2%
Free Cash Flow
-51.7%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-4.6
FCF per Share
$-4.2
Short interest
7.6%
Employees
167
Rev per Employee
$0.0
Show more

Is CARGO Therapeutics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

CARGO Therapeutics Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a CARGO Therapeutics forecast:

7x Hold
64%
4x Sell
36%

Analyst Opinions

11 Analysts have issued a CARGO Therapeutics forecast:

Hold
64%
Sell
36%

Financial data from CARGO Therapeutics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 42 42
14% 14%
-
- Research and Development Expense 114 114
3% 3%
-
-147 -147
3% 3%
-
- Depreciation and Amortization 7.70 7.70
256% 256%
-
EBIT (Operating Income) EBIT -155 -155
1% 1%
-
Net Profit -222 -222
50% 50%
-

In millions USD.

Don't miss a Thing! We will send you all news about CARGO Therapeutics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CARGO Therapeutics Stock News

Neutral
Business Wire
18 days ago
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating CARGO (NASDAQ: CRGX) for possible breaches of fiduciary duty and other violations of law in its transaction with Concentra Biosciences. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transa...
Neutral
Business Wire
about one month ago
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of CARGO Therapeutics, Inc. (NasdaqGS: CRGX) to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Concentra will acquire CARGO for $4.379 in cash per share, plus one non-transferable...
Neutral
GlobeNewsWire
about 2 months ago
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
More CARGO Therapeutics News

Company Profile

Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Mateo, CA.

Head office United States
CEO Anup Radhakrishnan
Employees 167
Founded 2019
Website cargo-tx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today